Edwards Lifesciences Corp.
(NYSE : EW)

( )
EW After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
-1.87%140.310.7%$420.97m
MDTMedtronic Plc
-0.75%111.220.6%$416.80m
ABTAbbott Laboratories
-1.70%84.250.8%$395.60m
TMOThermo Fisher Scientific, Inc.
-2.10%300.381.0%$360.95m
BDXBecton, Dickinson & Co.
-2.01%243.321.1%$337.37m
SYKStryker Corp.
-0.61%205.001.3%$335.02m
BAXBaxter International, Inc.
-0.39%81.121.8%$322.46m
ISRGIntuitive Surgical, Inc.
-0.08%569.092.4%$317.50m
BSXBoston Scientific Corp.
-0.02%42.301.1%$301.24m
EWEdwards Lifesciences Corp.
-1.32%242.411.2%$282.22m
ALGNAlign Technology, Inc.
1.74%268.516.4%$266.82m
WMGIWright Medical Group NV
-0.20%29.458.3%$265.88m
DXCMDexCom, Inc.
2.60%213.788.3%$259.65m
PODDInsulet Corp.
1.19%182.496.7%$148.39m
ABMDABIOMED, Inc.
-20.22%178.093.3%$143.28m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..